ProbarE AB är ett företag som bedriver kliniska läkemedelsprövningar. En livsviktig forskning, där din insats kan ge både dig själv och andra ett friskare liv.

Does fear of COPD exacerbations prevent you from leaving home?

Interested?

To learn more about this study, contact:
Ewa Karlsson, phone 0732-300 450 or email ewa.karlsson@probare.se

The clinical research study ENDURA-1 is currently seeking volunteers to evaluate an investigational medication for adults with COPD.

Chronic obstructive pulmonary disease (COPD) is a broad term that includes several ongoing lung diseases such as emphysema and chronic bronchitis. Common signs and symptoms may include breathing difficulties, fatigue, and a chronic cough (with or without mucus). Symptoms can sometimes get worse, which is known as “exacerbations.” These flare-ups can cause additional damage to the lungs, so it is important to treat COPD effectively.

A research study is currently enrolling adults with uncontrolled moderate to severe COPD. Study doctors are evaluating an investigational medication — a type of biologic medicine given as injections just under the skin.

They want to see whether it can reduce the number of moderate/severe exacerbations (symptom flare-ups) and improve symptoms and quality of life compared with placebo* when used as an add-on treatment. Researchers also want to assess how safe the investigational medication is in this population.

*Injections that do not contain any medication.

You may qualify to participate in this study if you:

  • Are between 40 and 80 years old.
  • Have moderate to severe COPD.
  • Are a current smoker OR a former smoker.
  • Have had at least one exacerbation (symptom flare-up) in the past 12 months that meets certain requirements.

The length of participation in the study varies depending on the participant but is expected to last at least 1 year and up to 2 years, during which an average of about one visit per month will be required.

Qualified participants will be reimbursed for study-related travel expenses and will be provided with the investigational medication or placebo, rescue medication, and study-related medical care.

NO INSURANCE REQUIRED.

Interested?

To learn more about this study, contact:
Ewa Karlsson, phone 0732-300 450 or email ewa.karlsson@probare.se